HEMATOLOGICAL MALIGNANCIES BIOBANK (CLL/AML)

Description

Scope 

Multicentric, homogeneous and annotated collections of clinico-biological data monitored as part of clinical trials, enabling projects to be conducted in the field of AML and CLL, such as: 

• New target discovery
• Biomarker research
• Patient stratification 

Provision of samples

Samples stored in the Filothèque can be made available to researchers for academic or industrial projects. This is done in compliance with the laws in force and is stipulated in the informed consent given to patients when they are enrolled in a FILO clinical trial. Requests for access to samples and associated data may be made in response to Filothèque's calls for tenders, or spontaneously by filling in the Sample Access Request Form and sending it to the indicated contact.

The provision of samples is subject to a fee to cover the costs of receipt, processing, conservation and removal from storage. 

 All projects are submitted to the Scientific Advisory Board for review and approval. Each approved project is the subject of a Material Transfer Contract between FILO and the concerned parties.

Infrastructure

• Samples and derived products are stored in mirror. Plasma, cells in dry pellets, cells in trizol and nucleic acids are stored at -80°. Viable cells are stored in nitrogen. Cryo-preservers are under permanent surveillance in controlled-access premises.
• Our technical staff are qualified by initial and ongoing training. For each operational task, a personnel authorization process is implemented and monitored.

Quality management 

• ISO 20 387 version 2018 certification